Stephen P. Squinto is an entrepreneur and businessperson who founded Alexion Pharmaceuticals, Inc., Passage Bio, Inc., Lyfebulb LLC and Gennao Bio, Inc. and who has been at the helm of 7 different companies. Currently, Dr. Squinto occupies the position of Chairman at Genenta Science Srl, Chairman for Lyfebulb LLC, Chairman of Chemomab Therapeutics Ltd., Chairman of Chemomab Ltd. (a subsidiary of Chemomab Therapeutics Ltd.), Chairman, President, Secretary & Treasurer at Gennao Bio, Inc. and Venture Partner at OrbiMed Advisors Private Equity.
He is also on the board of 15 other companies.
In his past career he occupied the position of Director, Head-Research & Development at Passage Bio, Inc., Senior Scientist & Assistant Head-Discovery Group at Regeneron Pharmaceuticals, Inc., Independent Director at Gemini Therapeutics Sub, Inc., Chief Global Operations Officer & Executive VP at Alexion Pharmaceuticals, Inc., Assistant Professor at Louisiana State University and President-Greater New Haven Chapter at Juvenile Diabetes Research Foundation Ltd.
Dr. Squinto received a doctorate and an undergraduate degree from Loyola University of Chicago.